These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20113451)

  • 41. Improved donor safety in high-volume apheresis collections.
    Vassallo RR; Bravo MD; Kamel H
    Transfusion; 2017 Feb; 57(2):319-324. PubMed ID: 27861957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An intervention study for the prevention of vasovagal reactions and evaluating donors' experience: Analysis of donors' return for subsequent donation.
    Wiersum-Osselton J; Prinsze F; van den Brekel E; van Dongen A; Hermans F; Bokhorst A; der Kreek TM
    Vox Sang; 2022 Mar; 117(3):313-320. PubMed ID: 34396539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Does using applied muscle tension at strategic time points during donation reduce phlebotomist- and donor-reported vasovagal reaction rates? A three-armed randomized controlled trial.
    Thijsen A; Gemelli CN; Davison TE; O'Donovan J; Bell B; Masser B
    Transfusion; 2018 Oct; 58(10):2352-2359. PubMed ID: 30222861
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving safety for young blood donors.
    Eder AF
    Transfus Med Rev; 2012 Jan; 26(1):14-26. PubMed ID: 21872427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood donor deferral pattern in Iran.
    Birjandi F; Gharehbaghian A; Delavari A; Rezaie N; Maghsudlu M
    Arch Iran Med; 2013 Nov; 16(11):657-60. PubMed ID: 24206408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rates and reasons for blood donor deferral, Shiraz, Iran. A retrospective study.
    Kasraian L; Negarestani N
    Sao Paulo Med J; 2015 Feb; 133(1):36-42. PubMed ID: 25166463
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increasing regular donors through a psychological approach which reduces the onset of vasovagal reactions.
    Pagliariccio A; Marinozzi M
    Transfus Apher Sci; 2012 Dec; 47(3):301-4. PubMed ID: 22727917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria.
    Okoroiwu HU; Asemota EA
    BMC Health Serv Res; 2019 Jul; 19(1):510. PubMed ID: 31331326
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extracorporeal blood volume of donors during automated intermittent-flow plasmapheresis and its relevance to the prevention of circulatory reactions.
    Karger R; Slonka J; Junck H; Kretschmer V
    Transfusion; 2003 Aug; 43(8):1096-106. PubMed ID: 12869116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Demographic correlates of low hemoglobin deferral among prospective whole blood donors.
    Mast AE; Schlumpf KS; Wright DJ; Custer B; Spencer B; Murphy EL; Simon TL;
    Transfusion; 2010 Aug; 50(8):1794-802. PubMed ID: 20412525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Donor complication rates in whole blood, plasma and platelet donors: Age versus experience.
    Paalvast Y; Díaz Padilla N; Bruijns S; Wiersum-Osselton J; Molenaar T
    Transfusion; 2024 May; 64(5):854-865. PubMed ID: 38385649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Donor deferral and resulting donor loss at the American Red Cross Blood Services, 2001 through 2006.
    Zou S; Musavi F; Notari EP; Rios JA; Trouern-Trend J; Fang CT
    Transfusion; 2008 Dec; 48(12):2531-9. PubMed ID: 18717777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vasovagal reactions in blood donors: risks, prevention and management.
    Thijsen A; Masser B
    Transfus Med; 2019 Apr; 29 Suppl 1():13-22. PubMed ID: 29148259
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized controlled trial of a tablet-based intervention to address predonation fears among high school donors.
    France CR; France JL; Kowalsky JM; Conatser R; Duffy L; Barnofsky N; Kessler D; Shaz B
    Transfusion; 2020 Jul; 60(7):1450-1453. PubMed ID: 32286685
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vasovagal reactions in blood donors during or immediately after blood donation.
    Zervou EK; Ziciadis K; Karabini F; Xanthi E; Chrisostomou E; Tzolou A
    Transfus Med; 2005 Oct; 15(5):389-94. PubMed ID: 16202053
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequency and risk factors for donor reactions in an anonymous blood donor survey.
    Goldman M; Osmond L; Yi QL; Cameron-Choi K; O'Brien SF
    Transfusion; 2013 Sep; 53(9):1979-84. PubMed ID: 23228195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence and severity of adverse events among platelet donors: A three-year retrospective study.
    Almutairi H; Salam M; Batarfi K; Alharbi D; Wani F; Almutairi A; Al-Shammari B; Al-Surimi K
    Medicine (Baltimore); 2020 Dec; 99(52):e23648. PubMed ID: 33350744
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
    Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
    Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Blood pre-donation deferrals--a teaching hospital experience.
    Rabeya Y; Rapiaah M; Rosline H; Ahmed SA; Zaidah WA; Roshan TM
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):571-4. PubMed ID: 18564700
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of interventions to prevent vasovagal reactions among whole blood donors: rationale and design of a large cluster randomised trial.
    McMahon A; Kaptoge S; Walker M; Mehenny S; Gilchrist PT; Sambrook J; Akhtar N; Sweeting M; Wood AM; Stirrups K; Chung R; Fahle S; Johnson E; Cullen D; Godfrey R; Duthie S; Allen L; Harvey P; Berkson M; Allen E; Watkins NA; Bradley JR; Kingston N; Miflin G; Armitage J; Roberts DJ; Danesh J; Di Angelantonio E
    Trials; 2023 Aug; 24(1):512. PubMed ID: 37563721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.